Pol Boudes
2017
In 2017, Pol Boudes earned a total compensation of $749.7K as Chief Medical Officer at Cymabay Therapeutics, a 23% increase compared to previous year.
Compensation breakdown
| Bonus | $206,645 |
|---|---|
| Option Awards | $126,800 |
| Salary | $393,610 |
| Other | $22,694 |
| Total | $749,749 |
Boudes received $393.6K in salary, accounting for 52% of the total pay in 2017.
Boudes also received $206.6K in bonus, $126.8K in option awards and $22.7K in other compensation.
Rankings
In 2017, Pol Boudes' compensation ranked 10,305th out of 14,666 executives tracked by ExecPay. In other words, Boudes earned more than 29.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,305 out of 14,666 | 30th |
Division Manufacturing | 3,994 out of 5,772 | 31st |
Major group Chemicals And Allied Products | 1,408 out of 2,075 | 32nd |
Industry group Drugs | 1,145 out of 1,731 | 34th |
Industry Pharmaceutical Preparations | 893 out of 1,333 | 33rd |
Source: SEC filing on April 20, 2018.
Boudes' colleagues
We found three more compensation records of executives who worked with Pol Boudes at Cymabay Therapeutics in 2017.